Vaccinex, Inc. Common Stock
VCNX
VCNX was delisted on the 17th of December, 2024.
22 hedge funds and large institutions have $995K invested in Vaccinex, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 5 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
8% less funds holding
Funds holding: 24 → 22 (-2)
10% less capital invested
Capital invested by funds: $1.1M → $995K (-$109K)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$159K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$27.2K |
| 3 |
Renaissance Technologies
New York
|
+$18.3K |
| 4 |
CC
Courier Capital
Buffalo,
New York
|
+$3.99K |
| 5 |
VRM
Vectors Research Management
New York
|
+$3.99K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$44K |
| 2 |
VF
Virtu Financial
New York
|
-$42K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$39.6K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$23.5K |
| 5 |
BlackRock
New York
|
-$19.7K |
VCNX Hedge Fund Activity: Q2 2023 in Review
22 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Vaccinex, Inc. Common Stock (VCNX) for Q2 2023, worth a combined $995K — down 9.8% from $1.1M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of VCNX and 4 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 4 added.
The largest buyer was AIGH Capital Management, adding an estimated $159K. The largest seller was Millennium Management, exiting entirely with an estimated $44K sold.
- 22 institutional investors held Vaccinex, Inc. Common Stock (VCNX) as of Q2 2023, down from 24 in Q1 2023.
- Funds reported $995K of Vaccinex, Inc. Common Stock stock for Q2 2023, down 9.8% quarter-over-quarter.
- 4 funds opened new Vaccinex, Inc. Common Stock positions in Q2 2023 and 5 closed out, a net change of -1 holder.
- The largest Vaccinex, Inc. Common Stock buyer in Q2 2023 was AIGH Capital Management, an estimated $159K added.
- The largest Vaccinex, Inc. Common Stock seller in Q2 2023 was Millennium Management, an estimated $44K sold.
Based on aggregated 13F filings for Q2 2023.